Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

With the recent convocation of the 119th Congress, a change in administration, and resignation of USPTO Director Vidal, pharmaceutical patent ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Chemical process enhances room temperature stability - - Provisional patent applications filed -PURCHASE, N.Y., Feb. 20, 2025 (GLOBE ...

Pharmaceuticals announced that a new patent has been granted by the Japanese Patent Office, JPO, in January 2025. This patent ...

ENCINITAS, CA - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), a small-cap biotech firm with a market capitalization of $10.47 million and strong financial health according to InvestingPro analysis, has ...

Obtaining regulatory approval for small-molecule therapeutics continues to be an arduous and expensive process ... crystals can expand patent protection and may help pharmaceutical companies ...

Adial Pharmaceuticals, Inc. has announced the issuance of a new patent that enhances their methods for identifying and treating patients with genetic markers associated with substance use ...

Eton has secured a patent from the USPTO for its ET-600 product candidate’s desmopressin oral solution formulation for ...

and we are proud to have developed a formulation to meet their needs and to see our innovation recognized with a patent,” said Sean Brynjelsen, CEO of Eton Pharmaceuticals. ET-600 previously ...

Adial secured a new U.S. patent expanding methods for identifying genetic markers linked to substance use disorders and AD04 treatment. The company completed a pharmacokinetics study confirming ...